I am not quite a 2.5m holder and not that hopeful either. We,...

I am not quite a 2.5m holder and not that hopeful either. We, investors, have got to be realistic. Lots of false promises; Oh the delays; No pharma interest to date; No notable smart money in the top 40. There is merely a small study showing some notable and question raising results. The cost to get this far is insane. One thing I'm fairly confident about with Biotron is that my $100k aic will be turned to dust. When that happens I do wonder how MM retires knowing she has wasted so much investor capital on a fruitless exercise. It is a penny to me but a warning to those who think a significant pharma might be interested in this tech after the current trials. Let's get real.